Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 44 Colorectal Neoplasms 22 Breast Neoplasms 22 Stomach Neoplasms 21 Neoplasms 18 Esophageal Squamous Cell Carcinoma 12 Neoplasm Metastasis 11 Nasopharyngeal Carcinoma 11 Lung Neoplasms 11 Rectal Neoplasms 9 Colonic Neoplasms 8 Pancreatic Neoplasms 7 Uterine Cervical Neoplasms 6 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Ovarian Neoplasms 5 Osteosarcoma 5 Brain Neoplasms 5 Small Cell Lung Carcinoma 4 Recurrence 4 Glioblastoma 4 Gastrointestinal Neoplasms 4 Precision Cell Immunotherapy 3 Melanoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Head and Neck Neoplasms 3 Gastrointestinal Diseases 3 Digestive System Neoplasms 3 Carcinoma, Ovarian Epithelial 3

Interventions

genexol-PM 1 Therapeutics 1 Radiotherapy, Intensity-Modulated 1 Preoperative Exercise 1 Population Groups 1 FloSeal Matrix 1 Exercise 1 Enhanced Recovery After Surgery 1 Drug Therapy 1 Diagnostic Tests, Routine 1 Diagnostic Imaging 1 Counseling 1 Cisplatin 1 AGuIX 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Gynecologic Cancer × Drug Therapy × Clear all

NCT03308604 2021-07-07

NANOCOL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Unknown

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡